Categories: Structured Products| Products| ETFs| Investment Trusts| Regulation
Topics: FSA| Civil Aviation Authority| Hector Sants| PanaceaIFA
Derek Bradley, CEO of PanaceaIFA.com, laments the FSA’s decision not to pre-approve financial products.
Last year, the FSA decided not to license or pre-approve financial services products. Chris Pond, head of consumer affairs at the FSA, maintains that ‘product pre-approval would have proved problematic’ and that ‘we have stepped away from the idea of saying we will approve products in advance because we do not have the resources.’
Consumer detriment has become more and more acute over the years. This has been perpetuated by regulators noting flaws in product design or marketing but, frustratingly, only taking action after the event.
Regulation should be about being smart before the event. It should be about utilising experience when things go wrong to make sure mistakes do not happen twice.
To look at it from the other side of the fence, those who manufacture financial products are in business to make a profit. That profit – like all profit – can exist within the bounds of ethics and honesty.
However, it is always apparent that the FSA just does not understand the markets it purports to regulate. Why else would it have made an announcement such as this?
To license a product as fit for purpose is the single most effective consumer benefit a regulator could put in place. It is the Civil Aviation Authority’s equivalent of labelling an aircraft as fit to fly, or the same as the Food Standards Agency confirming a product as safe to eat.
I maintain that the decision not to license or pre-approve financial services products is nothing to do with resource, but with responsibility and who the finger points at when things go wrong.
One must remember that, as FSA chief executive Hector Sants pointed out last year, if responsibility fell upon the shoulders of those at the FSA, nobody would want to do the job.
A regulator cannot rely on someone else to do its job, and then get them to take the blame when it all ends in tears.
It has been suggested that the extra resource needed would result in a huge increase in fees. In the short term, perhaps yes. However, if financial products were appropriately licensed there would inherently be fewer failures.
In any event, the FSA has certainly never found it difficult to raise money. It just goes to the very banks it regulates to raise the money then bills those it regulates to pay it back.
This is a debate which will continue to rage and the FSA needs to lead the charge. It can do this by demonstrating to the IFA community the importance of taking responsibility for all its actions.
| Share | |
| Comment | Fit to fly and safe to eat, so why not good to buy? |
More from professional adviser
Email alerts
Recommended reading
Categories
Topics
Comments
Related articles
Most Read
This year we have 14 awards designed to mark out the very best products in a highly competitive and innovative market. This includes three new awards for 2011 to reflect the developments in this rapidly growing market: Best Dual/Multi-Index Product, Best Structured (Oeic) Fund and Best Structured Product Provider.
Events
Poll
|
|
Job search
Ifaonlinejobs will open the right investment career path for you. Search hundreds of vacancies on www.ifaonlinejobs.co.uk now
In Focus
Investments generally carry two key risks, systematic risk and unsystematic risk.
Viewpoints
Watch Gary Dale and Lawrence Gosling discuss where structured investments could and should...
Why does it take so long for common sense to prevail
Products should be 'pre-approved' . The benefits are clearer communications for customers, reduced risk of mis-selling and mis-buying, (theoretical) dilution of the compliance burden = fewer cushy jobs at Canary Wharf, and elimination of the risk of the less capable advisers meddling in things they know little about. The frightening thing about many so-called advisers is that they are blissfully unaware they know too little about their subject. I for one know where my limit lies regarding technicalites. The one more upside of 'approving products' is to reduce the debacle of the Keydata saga in 2011, when many advisers had to find £500 as their contribution to the mess, even if they had NEVER sold one of these products
Posted by: Graham